sulotroban has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, T; Bove, AA; Deutsch, E; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, A; Vetrovec, G; Whitworth, HB | 1 |
| Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
| Bulitta, M; Etti, H; Finci, L; Höfling, B; Ludwig, B; Meier, B; Steffenino, G | 1 |
3 trial(s) available for sulotroban and Recrudescence
| Article | Year |
|---|---|
Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sulfonamides; Thromboxane A2; Time Factors; Treatment Outcome | 1995 |
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
Sulotroban during and after coronary angioplasty. A double-blind, placebo controlled study.
Topics: Angioplasty, Balloon; Anti-Arrhythmia Agents; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Randomized Controlled Trials as Topic; Recurrence; Sulfonamides | 1989 |